Terumo BCT

Antoinette Gawin, President
Lakewood, CO
(Private)
As a global leader in blood component, therapeutic apheresis, cellular and autologous biologic technologies, Terumo BCT believes in the potential of cells to do even more for patients than they do currently. As innovators for over 40 years in cell separation, the company is committed to providing autologous biologic technologies that deliver consistently reproducible results that clinicians and healthcare organizations trust. Through Terumo’s service and support, the company enables physicians to use cutting-edge technologies, increase patient access to autologous therapies and continue to advance next-generation technology.
www.terumobct.com